BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 36247822)

  • 1. Macular Pigment Response to Lutein, Zeaxanthin, and Meso-zeaxanthin Supplementation in Open-Angle Glaucoma: A Randomized Controlled Trial.
    Loughman J; Loskutova E; Butler JS; Siah WF; O'Brien C
    Ophthalmol Sci; 2021 Sep; 1(3):100039. PubMed ID: 36247822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
    Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
    JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower Macular Pigment Optical Density in Foveal-Involved Glaucoma.
    Siah WF; Loughman J; O'Brien C
    Ophthalmology; 2015 Oct; 122(10):2029-37. PubMed ID: 26249732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular pigment is associated with glare-affected visual function and central visual field loss in glaucoma.
    Siah WF; O'Brien C; Loughman JJ
    Br J Ophthalmol; 2018 Jul; 102(7):929-935. PubMed ID: 28982957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects - A Prospective Diagnostic Study.
    Bruns Y; Junker B; Boehringer D; Framme C; Pielen A
    Clin Ophthalmol; 2020; 14():1011-1017. PubMed ID: 32308361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
    Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula.
    Davey PG; Henderson T; Lem DW; Weis R; Amonoo-Monney S; Evans DW
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements.
    Obana A; Tanito M; Gohto Y; Okazaki S; Gellermann W; Bernstein PS
    PLoS One; 2015; 10(10):e0139257. PubMed ID: 26451726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study.
    Jaggi D; Solberg Y; Dysli C; Lincke J; Habra O; Wyss A; Wolf S; Zinkernagel M
    Clin Nutr ESPEN; 2023 Aug; 56():127-134. PubMed ID: 37344061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial.
    Akuffo KO; Beatty S; Peto T; Stack J; Stringham J; Kelly D; Leung I; Corcoran L; Nolan JM
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5347-5360. PubMed ID: 29053808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration.
    Weigert G; Kaya S; Pemp B; Sacu S; Lasta M; Werkmeister RM; Dragostinoff N; Simader C; Garhöfer G; Schmidt-Erfurth U; Schmetterer L
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8174-8. PubMed ID: 21873668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial profile of macular pigment and its relationship to foveal architecture.
    Nolan JM; Stringham JM; Beatty S; Snodderly DM
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Commercially Available Nutritional Supplements: Analysis of Serum Uptake, Macular Pigment Optical Density and Visual Functional Response.
    Bone RA; Davey PG; Roman BO; Evans DW
    Nutrients; 2020 May; 12(5):. PubMed ID: 32384663
    [No Abstract]   [Full Text] [Related]  

  • 18. Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery.
    Stringham JM; O'Brien KJ; Stringham NT
    Eye Vis (Lond); 2016; 3():30. PubMed ID: 27857944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
    Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
    Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study.
    Merle BMJ; Buaud B; Korobelnik JF; Bron A; Delyfer MN; Rougier MB; Savel H; Vaysse C; Creuzot-Garcher C; Delcourt C
    Acta Ophthalmol; 2017 Dec; 95(8):e763-e769. PubMed ID: 28271618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.